Clinical Support Solution Using an Integrated Medical IT Archive

「In April 2026, we launched SYNAPSE LEAD Cloud, a cloud-based medical image information system, as a new addition to the PACS lineup,」

「The Company also launched “EW10-US01,” an ultrasound endoscopy diagnostic support software that detects in real time areas suspected of containing solid pancreatic lesions, typified by pancreatic cancer, during endoscopic ultrasound examinations and supports the early detection of pancreatic cancer, through the company in December 2025.」

「Medical IT, where sales of systems and services centered on the picture archiving and communication system (PACS) “SYNAPSE” performed well in Japan, the United States, the Middle East and elsewhere」

「In the medical IT field, sales of systems and services centered on the picture archiving and communication system (PACS) “SYNAPSE” and the 3D image analysis system “SYNAPSE VINCENT” remained strong in the United States, Europe, India and elsewhere, but revenue declined due to the impact of the transfer of the electronic medical records and medical claims-related business in October 2023.」

「In the medical IT field, sales of systems and services centered on the picture archiving and communication system (PACS) “SYNAPSE” and the 3D image analysis system “SYNAPSE VINCENT” remained strong, particularly in overseas markets such as the United States and Europe, increasing revenue.」

「In the medical IT field, sales of systems and services centered on the picture archiving and communication system (PACS) “SYNAPSE” and the 3D image analysis system “SYNAPSE VINCENT” grew, particularly in the United States and Europe, increasing revenue.」

「In the medical IT field, sales of systems and services centered on the picture archiving and communication system (PACS) “SYNAPSE” and the 3D image analysis system “SYNAPSE VINCENT” grew, particularly in overseas markets such as the United States, Europe and China, increasing revenue.」

「The company obtained marketing authorisation under Japan's Pharmaceuticals and Medical Devices Act for EW10-EG01, endoscopy diagnostic support software that detects in real time areas suspected of containing gastric neoplastic lesions or oesophageal squamous cell carcinoma during upper gastrointestinal endoscopy and supports the early detection of stomach and oesophageal cancer.」

「By combining the company's globally leading medical image information system (PACS) with this digital pathology diagnostic software, the company will centralise examination images within hospitals, including pathology images, and support greater efficiency in pathology diagnostic workflows.」

「In September 2022, EW10-EG01, an endoscopy diagnostic support software supporting the early detection of stomach and oesophageal cancer, obtained Japan's first marketing authorisation as a medical device for endoscopy diagnosis in the upper gastrointestinal tract developed using AI technology.」

「In the medical IT field, sales of systems and services centred on the SYNAPSE medical image information system (PACS) and the 3D image-analysis system SYNAPSE VINCENT grew substantially, particularly in Japan, resulting in higher sales.」

「In June 2022, the company launched SYNAPSE VINCENT Cloud, a service that enables applications for the 3D image-analysis system SYNAPSE VINCENT to be used through the cloud. In addition, it planned to launch during fiscal 2022 SYNAPSE Creative Space, a cloud service using a research platform system for AI technology development developed jointly with the National Cancer Center, enabling physicians and researchers to develop image-diagnosis support AI technologies themselves without specialised knowledge such as programming.」

「In August 2021, the company launched CXR-AID, software for detecting lesions in chest X-ray images that supports the diagnosis of lung cancer, pneumonia and pneumothorax using AI technology.」

「Since launching a new application for SYNAPSE VINCENT in April 2021, the company has placed greater emphasis on developing AI technologies that can be used to support medical image diagnosis and workflows in medical settings.」

「In May 2021, the company launched a medical cloud service that provides applications for its SYNAPSE SAI viewer AI platform through the cloud, making image-diagnosis support functions more accessible to users according to the budgets and operating environments of their medical institutions.」

「In the medical IT field, under the REiLI brand, the company is developing and commercialising AI technologies that support workflows in medical settings. Using these AI and IT technologies, it aims to further expand its AI and IT solutions business by leveraging a broad product lineup comprising X-ray imaging and diagnostic equipment, endoscopes, portable ultrasound systems and in vitro diagnostics (IVD), as well as CT, MRI and cart-based ultrasound systems newly added through the acquisition.」

「In November 2020, the company launched in Japan CAD EYE™, an endoscopy diagnostic support function using AI technology to support the real-time detection and differentiation of lesions such as colorectal polyps.」

「In August 2020, the company began sales in Japan of the 3D image-analysis system SYNAPSE VINCENT Ver.6.1, equipped with applications designed using AI technology, including an automatic organ-extraction function.」

「In June 2020, the company launched an application for SYNAPSE SAI viewer that uses AI technology to support the detection of pulmonary nodules in chest CT images for lung cancer diagnosis.」

「In the medical IT field, under the brand name REiLI, the company is developing and commercialising AI technologies that support workflows in medical settings.」

「In Japan, the company began selling SYNAPSE SAI viewer in July 2019, an AI platform that supports diagnosis using AI technologies such as automatic extraction of organs from CT images. Through the use of AI technology, the company will work to support physicians' diagnosis and improve workflows in image diagnosis.」

「In the medical IT field, sales of systems centred on the SYNAPSE medical image information system (PACS) remained strong, particularly in Japan and the United States.」

「In the field of the SYNAPSE medical image information system (PACS), the company developed SYNAPSE SAI viewer, an AI platform that supports image-diagnosis workflows using AI technologies such as automatic extraction of organs from CT images and display of chronological changes in bones. The company is also advancing industry-academia collaboration, including by signing a joint research agreement with Indiana University School of Medicine on the development of a medical image-diagnosis support system using AI technologies and successfully co-developing with the Kyoto University Graduate School of Medicine's Department of Respiratory Medicine a technology that automatically classifies and quantifies interstitial pneumonia lesions with high accuracy.」

「In the medical IT field, sales of systems centred on the SYNAPSE medical image information system (PACS) remained strong in the United States.」

「In the medical IT field, sales of systems centred on the SYNAPSE medical image information system (PACS) remained strong.」

「In the medical IT field, the company began selling SYNAPSE VNA, an integrated archive system that centrally manages and stores diverse clinical information, including diagnostic images and videos stored in systems used by different hospital departments and in medical image information systems (PACS) from different manufacturers, in Japan in April 2016. In May, it also began selling SYNAPSE 5, a PACS that doubles image-processing and display speeds compared with previous systems and contributes to improved diagnostic efficiency for physicians, further strengthening its proposals for solutions that are more efficient and contribute to diagnosis.」

「In the medical IT field, the company began selling SYNAPSE VNA, an integrated archive system that centrally manages and stores diverse clinical information, including diagnostic images and videos stored in systems used by different hospital departments and in medical image information systems (PACS) from different manufacturers, in Japan in April 2016. In May, it also began selling SYNAPSE 5, a PACS that doubles image-processing and display speeds compared with previous systems and contributes to improved diagnostic efficiency for physicians, further strengthening its proposals for solutions that are more efficient and contribute to diagnosis.」

「In the medical IT field, the company began selling SYNAPSE VNA, an integrated archive system that centrally manages and stores diverse clinical information, including diagnostic images and videos stored in systems used by different hospital departments and in medical image information systems (PACS) from different manufacturers, in Japan in April 2016. In May, it also began selling SYNAPSE 5, a PACS that doubles image-processing and display speeds compared with previous systems and contributes to improved diagnostic efficiency for physicians, further strengthening its proposals for solutions that are more efficient and contribute to diagnosis.」

「Following the consolidation of US medical IT systems manufacturer TeraMedica, Inc. as a subsidiary in May 2015, the Group will combine the company's integrated archive system, which efficiently manages and stores clinical information within hospitals, including diagnostic images in PACS, with the Group's systems to propose solutions that are more efficient and contribute to diagnosis.」